BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9621085)

  • 1. Woodchuck hepatitis virus enhancer I and enhancer II are both involved in N-myc2 activation in woodchuck liver tumors.
    Flajolet M; Tiollais P; Buendia MA; Fourel G
    J Virol; 1998 Jul; 72(7):6175-80. PubMed ID: 9621085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the N-myc2 oncogene by woodchuck hepatitis virus integration in the linked downstream b3n locus in woodchuck hepatocellular carcinoma.
    Bruni R; D'Ugo E; Giuseppetti R; Argentini C; Rapicetta M
    Virology; 1999 May; 257(2):483-90. PubMed ID: 10329558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepadnavirus integration: mechanisms of activation of the N-myc2 retrotransposon in woodchuck liver tumors.
    Wei Y; Fourel G; Ponzetto A; Silvestro M; Tiollais P; Buendia MA
    J Virol; 1992 Sep; 66(9):5265-76. PubMed ID: 1323693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The win locus involved in activation of the distal N-myc2 gene upon WHV integration in woodchuck liver tumors harbors S/MAR elements.
    Bruni R; D'Ugo E; Villano U; Fourel G; Buendia MA; Rapicetta M
    Virology; 2004 Nov; 329(1):1-10. PubMed ID: 15476869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of WHV integration nearby N-myc2 and in the downstream b3n and win loci in a considerable fraction of liver tumors with activated N-myc2 from naturally infected wild woodchucks.
    Bruni R; Conti I; Villano U; Giuseppetti R; Palmieri G; Rapicetta M
    Virology; 2006 Feb; 345(1):258-69. PubMed ID: 16271377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The HNF1/HNF4-dependent We2 element of woodchuck hepatitis virus controls viral replication and can activate the N-myc2 promoter.
    Fourel G; Ringeisen F; Flajolet M; Tronche F; Pontoglio M; Tiollais P; Buendia MA
    J Virol; 1996 Dec; 70(12):8571-83. PubMed ID: 8970982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular and viral trans-acting factors modulate N-myc2 promoter activity in woodchuck liver tumors.
    Flajolet M; Gegonne A; Ghysdael J; Tiollais P; Buendia MA; Fourel G
    Oncogene; 1997 Aug; 15(9):1103-10. PubMed ID: 9285565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of N-myc2 gene expression by cis-acting elements of oncogenic hepadnaviral genomes: key role of enhancer II.
    Ueda K; Wei Y; Ganem D
    Virology; 1996 Mar; 217(1):413-7. PubMed ID: 8599232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for long-range oncogene activation by hepadnavirus insertion.
    Fourel G; Couturier J; Wei Y; Apiou F; Tiollais P; Buendia MA
    EMBO J; 1994 Jun; 13(11):2526-34. PubMed ID: 8013453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scaffold attachment region located in a locus targeted by hepadnavirus integration in hepatocellular carcinomas.
    Bruni R; D'Ugo E; Argentini C; Giuseppetti R; Rapicetta M
    Cancer Detect Prev; 2003; 27(3):175-81. PubMed ID: 12787723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Woodchuck hepatitis virus DNA integration in a common chromosomal region of the woodchuck genome in two independent hepatocellular carcinomas.
    Bruni R; Argentini C; D'Ugo E; Giuseppetti R; Rapicetta M
    Arch Virol; 1997; 142(3):499-509. PubMed ID: 9349296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antisense downregulation of N-myc1 in woodchuck hepatoma cells reverses the malignant phenotype.
    Wang HP; Zhang L; Dandri M; Rogler CE
    J Virol; 1998 Mar; 72(3):2192-8. PubMed ID: 9499076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the woodchuck N-myc2 retroposon in brain and in liver tumors is driven by a cryptic N-myc promoter.
    Fourel G; Transy C; Tennant BC; Buendia MA
    Mol Cell Biol; 1992 Dec; 12(12):5336-44. PubMed ID: 1333041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo effects of mutations in woodchuck hepatitis virus enhancer II.
    Wei Y; Tennant B; Ganem D
    J Virol; 1998 Aug; 72(8):6608-13. PubMed ID: 9658106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple rearrangements and activated expression of c-myc induced by woodchuck hepatitis virus integration in a primary liver tumour.
    Wei Y; Ponzetto A; Tiollais P; Buendia MA
    Res Virol; 1992; 143(2):89-96. PubMed ID: 1317604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma in WHV/N-myc2 transgenic mice: oncogenic mutations of beta-catenin and synergistic effect of p53 null alleles.
    Renard CA; Fourel G; Bralet MP; Degott C; De La Coste A; Perret C; Tiollais P; Buendia MA
    Oncogene; 2000 May; 19(22):2678-86. PubMed ID: 10851067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular factors controlling the activity of woodchuck hepatitis virus enhancer II.
    Ueda K; Wei Y; Ganem D
    J Virol; 1996 Jul; 70(7):4714-23. PubMed ID: 8676498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for a bidirectional promoter complex within the X gene of woodchuck hepatitis virus.
    Shimoda A; Sugata F; Chen HS; Miller RH; Purcell RH
    Virus Res; 1998 Jul; 56(1):25-39. PubMed ID: 9784063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integration of woodchuck hepatitis and N-myc rearrangement determine size and histologic grade of hepatic tumors.
    Jacob JR; Sterczer A; Toshkov IA; Yeager AE; Korba BE; Cote PJ; Buendia MA; Gerin JL; Tennant BC
    Hepatology; 2004 Apr; 39(4):1008-16. PubMed ID: 15057905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrence of WHV integration in the b3n locus in woodchuck hepatocellular carcinoma.
    Bruni R; Argentini C; D'Ugo E; Giuseppetti R; Ciccaglione AR; Rapicetta M
    Virology; 1995 Dec; 214(1):229-34. PubMed ID: 8525620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.